Radiosensitization of non-small cell lung carcinoma by EGFR inhibition

Radiosensitization of non-small cell lung carcinoma by EGFR inhibition

Molecular targeted cancer therapy is a promising treatment strategy. Considering the central role of the epidermal growth factor receptor in cell proliferation and survival, there are indications that targeted agents like tyrosine kinase inhibitors, i. e., erlotinib, may enhance the antitum...

Descrizione completa

Dettagli Bibliografici
Autori principali: Keta Otilija D., Bulat Tanja M., Korićanac Lela B., Žakula Jelena J., Cuttone Giacomo, Privitera Giuseppe, Petrović Ivan M., Ristić-Fira Aleksandra M.
Natura: Articolo
Lingua:English
Pubblicazione: VINCA Institute of Nuclear Sciences 2014-01-01
Serie:Nuclear Technology and Radiation Protection
Soggetti:
human lung adenocarcinoma cell
γ-ray
DNA damage
erlotinib
radiosensitization
Accesso online:http://www.doiserbia.nb.rs/img/doi/1451-3994/2014/1451-39941403233K.pdf

Accesso online

http://www.doiserbia.nb.rs/img/doi/1451-3994/2014/1451-39941403233K.pdf

Documenti analoghi